The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Measles and Rubella Vaccine Market Research Report 2024
Synopsis
Measles and Rubella Vaccine is a live virus vaccine used to vaccinate against measles and rubella.
Global Measles and Rubella Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Measles and Rubella Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Measles and Rubella Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Serum Institute of India Pvt. Ltd.
Incepta Vaccine Ltd.
GSK
Sanofi
Segment by Type
Inactivated Vaccines
Live Attenuated Vaccines
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Measles and Rubella Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Measles and Rubella Vaccine is a live virus vaccine used to vaccinate against measles and rubella.
Global Measles and Rubella Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Measles and Rubella Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Measles and Rubella Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Serum Institute of India Pvt. Ltd.
Incepta Vaccine Ltd.
GSK
Sanofi
Segment by Type
Inactivated Vaccines
Live Attenuated Vaccines
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Measles and Rubella Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Measles and Rubella Vaccine Market Overview
1.1 Product Overview and Scope of Measles and Rubella Vaccine
1.2 Measles and Rubella Vaccine Segment by Type
1.2.1 Global Measles and Rubella Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Inactivated Vaccines
1.2.3 Live Attenuated Vaccines
1.3 Measles and Rubella Vaccine Segment by Application
1.3.1 Global Measles and Rubella Vaccine Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Measles and Rubella Vaccine Market Size Estimates and Forecasts
1.4.1 Global Measles and Rubella Vaccine Revenue 2018-2029
1.4.2 Global Measles and Rubella Vaccine Sales 2018-2029
1.4.3 Global Measles and Rubella Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Measles and Rubella Vaccine Market Competition by Manufacturers
2.1 Global Measles and Rubella Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Measles and Rubella Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Measles and Rubella Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Measles and Rubella Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Measles and Rubella Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles and Rubella Vaccine, Product Type & Application
2.7 Measles and Rubella Vaccine Market Competitive Situation and Trends
2.7.1 Measles and Rubella Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Measles and Rubella Vaccine Players Market Share by Revenue
2.7.3 Global Measles and Rubella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measles and Rubella Vaccine Retrospective Market Scenario by Region
3.1 Global Measles and Rubella Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Measles and Rubella Vaccine Global Measles and Rubella Vaccine Sales by Region: 2018-2029
3.2.1 Global Measles and Rubella Vaccine Sales by Region: 2018-2023
3.2.2 Global Measles and Rubella Vaccine Sales by Region: 2024-2029
3.3 Global Measles and Rubella Vaccine Global Measles and Rubella Vaccine Revenue by Region: 2018-2029
3.3.1 Global Measles and Rubella Vaccine Revenue by Region: 2018-2023
3.3.2 Global Measles and Rubella Vaccine Revenue by Region: 2024-2029
3.4 North America Measles and Rubella Vaccine Market Facts & Figures by Country
3.4.1 North America Measles and Rubella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Measles and Rubella Vaccine Sales by Country (2018-2029)
3.4.3 North America Measles and Rubella Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Measles and Rubella Vaccine Market Facts & Figures by Country
3.5.1 Europe Measles and Rubella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Measles and Rubella Vaccine Sales by Country (2018-2029)
3.5.3 Europe Measles and Rubella Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles and Rubella Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Measles and Rubella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Measles and Rubella Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Measles and Rubella Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Measles and Rubella Vaccine Market Facts & Figures by Country
3.7.1 Latin America Measles and Rubella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Measles and Rubella Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Measles and Rubella Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measles and Rubella Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles and Rubella Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Measles and Rubella Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Measles and Rubella Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles and Rubella Vaccine Sales by Type (2018-2029)
4.1.1 Global Measles and Rubella Vaccine Sales by Type (2018-2023)
4.1.2 Global Measles and Rubella Vaccine Sales by Type (2024-2029)
4.1.3 Global Measles and Rubella Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Measles and Rubella Vaccine Revenue by Type (2018-2029)
4.2.1 Global Measles and Rubella Vaccine Revenue by Type (2018-2023)
4.2.2 Global Measles and Rubella Vaccine Revenue by Type (2024-2029)
4.2.3 Global Measles and Rubella Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Measles and Rubella Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Measles and Rubella Vaccine Sales by Application (2018-2029)
5.1.1 Global Measles and Rubella Vaccine Sales by Application (2018-2023)
5.1.2 Global Measles and Rubella Vaccine Sales by Application (2024-2029)
5.1.3 Global Measles and Rubella Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Measles and Rubella Vaccine Revenue by Application (2018-2029)
5.2.1 Global Measles and Rubella Vaccine Revenue by Application (2018-2023)
5.2.2 Global Measles and Rubella Vaccine Revenue by Application (2024-2029)
5.2.3 Global Measles and Rubella Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Measles and Rubella Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Measles and Rubella Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Measles and Rubella Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Serum Institute of India Pvt. Ltd.
6.2.1 Serum Institute of India Pvt. Ltd. Corporation Information
6.2.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
6.2.3 Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Product Portfolio
6.2.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
6.3 Incepta Vaccine Ltd.
6.3.1 Incepta Vaccine Ltd. Corporation Information
6.3.2 Incepta Vaccine Ltd. Description and Business Overview
6.3.3 Incepta Vaccine Ltd. Measles and Rubella Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Incepta Vaccine Ltd. Measles and Rubella Vaccine Product Portfolio
6.3.5 Incepta Vaccine Ltd. Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Measles and Rubella Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK Measles and Rubella Vaccine Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Measles and Rubella Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sanofi Measles and Rubella Vaccine Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles and Rubella Vaccine Industry Chain Analysis
7.2 Measles and Rubella Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles and Rubella Vaccine Production Mode & Process
7.4 Measles and Rubella Vaccine Sales and Marketing
7.4.1 Measles and Rubella Vaccine Sales Channels
7.4.2 Measles and Rubella Vaccine Distributors
7.5 Measles and Rubella Vaccine Customers
8 Measles and Rubella Vaccine Market Dynamics
8.1 Measles and Rubella Vaccine Industry Trends
8.2 Measles and Rubella Vaccine Market Drivers
8.3 Measles and Rubella Vaccine Market Challenges
8.4 Measles and Rubella Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
